AG-120 (racemic)

CAS No. 1448346-63-1

AG-120 (racemic)( —— )

Catalog No. M23614 CAS No. 1448346-63-1

AG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 93 In Stock
5MG 69 In Stock
10MG 107 In Stock
25MG 180 In Stock
50MG 263 In Stock
100MG 390 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AG-120 (racemic)
  • Note
    Research use only, not for human use.
  • Brief Description
    AG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.
  • Description
    AG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    IDH1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1448346-63-1
  • Formula Weight
    582.96
  • Molecular Formula
    C28H22ClF3N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/ml (171.54 mM); Ethanol:100 mg/ml (171.54 mM)
  • SMILES
    O=C1CC[C@@H](C(N(C(C(NC2CC(F)(F)C2)=O)C3=CC=CC=C3Cl)C4=CC(F)=CN=C4)=O)N1C5=NC=CC(C#N)=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.M Cecilia Caino, Dario C Altieri. Clin Cancer Res. 2016 Feb 1;22(3):540-5.
molnova catalog
related products
  • Qc1

    Qc1 is an inhibitor of threonine dehydrogenase (TDH) inhibitor and can be used in studies about metabolic diseases.

  • BI?3231

    BI?3231 is a selective and potent inhibitor of hydroxysteroid 17?-dehydrogenase 13 HSD17B13, inhibiting hHSD17B13 and mHSD17B13.BI-3231 can be used for the study of alcohol-associated liver injury, fibrosis and cirrhosis.

  • MF-438

    MF-438 is an effective and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor (EC50: 2.3 nM for rSCD1). In a mouse model, MF-438 shows an ED50 between 1 and 3 mg/kg.